Showing 201-210 of 1741 results for "".
Epilepsy Essentials: Physical Activity and Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-physical-activity-and-epilepsy/31775/Neurologists can be comfortable prescribing exercise as part of an overall health plan for people with epilepsy.Psychiatric Comorbidities in Functional Neurologic Symptom Disorder
https://practicalneurology.com/diseases-diagnoses/movement-disorders/psychiatric-comorbidities-in-functional-neurologic-symptom-disorder/31889/Attachment deficits in the context of psychosocial factors may explain the presence of functional neurologic disorder.Stroke Snapshot: Acute Ischemic Stroke
https://practicalneurology.com/diseases-diagnoses/stroke/stroke-snapshot-acute-ischemic-stroke/31855/Advances in stroke care are abundant.Neuroimaging Traumatic Brain Injuries
https://practicalneurology.com/diseases-diagnoses/tbi/neuroimaging-traumatic-brain-injuries/31599/Imaging is of paramount importance to the overall care of people with TBIsOptimizing Outcomes in AAD in Community PCP and LTC Clinics
https://practicalneurology.com/programs/cme/optimizing-outcomes-in-aad-in-community-pcp-and-ltc-clinics/26712/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Clinical Use of Dementia Biomarkers to Evaluate Cognitive Deficits in People With Primary Psychiatric Disorders
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/clinical-use-of-dementia-biomarkers-to-evaluate-cognitive-deficits-in-people-with-primary-psychiatric-disorders/32101/Biomarkers may assist in identifying whether symptoms are the result of the primary psychiatric process or a neurodegenerative process.Traumatic Brain Injury in Older Adults: Epidemiology, Management, Outcomes
https://practicalneurology.com/diseases-diagnoses/tbi/traumatic-brain-injury-in-older-adults-epidemiology-management-outcomes/31987/Unique features of traumatic brain injuries in older adults and the current landscape of treatment and management optionsBuilding Better Strategies: Incorporating New AAD Treatments Into Clinical Practice
https://practicalneurology.com/programs/cme/building-better-strategies-incorporating-new-aad-treatments-into-clinical-practice/27102/Tune in to learn about diagnosing and treating agitation in Alzheimer’s disease in primary care and long-term care settings.Treatment Response Assessment Tools for Relapsing Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/treatment-response-assessment-tools-for-relapsing-multiple-sclerosis/33142/The authors explore available tools for assessing treatment response in relapsing multiple sclerosis and provide practical recommendations for their use in clinical practice.Multiple Sclerosis Minute: Novel Treatment Options for Neuromyelitis Optica Spectrum Disorder
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/multiple-sclerosis-minute-novel-treatment-options-for-neuromyelitis-opticaspectrum-disorder/31844/Relapse prevention is critical for preventing the accumulation of disability in NMOSD and new monoclonal antibody therapies are highly effective at doing so.